How big is the Amniotic Membrane Market?

The Amniotic Membrane Market size is expected to reach USD 2.99 billion in 2024 and grow at a CAGR of 12.10% to reach USD 4.26 billion by 2029. Read More

What is the current Amniotic Membrane Market size?

In 2024, the Amniotic Membrane Market size is expected to reach USD 2.99 billion. Read More

Who are the key players in Amniotic Membrane Market?

Human Regenerative Technologies, LLC, Katena Products. Inc., MIMEDX, Amnio Technology, LLC and TissueTech, Inc. (BioTissue) are the major companies operating in the Amniotic Membrane Market. Read More

Which is the fastest growing region in Amniotic Membrane Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Amniotic Membrane Market?

In 2024, the North America accounts for the largest market share in Amniotic Membrane Market. Read More

What years does this Amniotic Membrane Market cover, and what was the market size in 2023?

In 2023, the Amniotic Membrane Market size was estimated at USD 2.63 billion. The report covers the Amniotic Membrane Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Amniotic Membrane Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Amniotic Membrane Market Share

Statistics for the 2023 & 2024 Amniotic Membrane market share, created by Mordor Intelligence™ Industry Reports. Amniotic Membrane share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Amniotic Membrane Industry

The amniotic membrane market is moderately competitive due to the presence of a few companies operating globally and regionally. The competitive landscape includes an analysis of some international and local companies that hold market shares and are well known, including Human Regenerative Technologies LLC, Katena Products Inc., Mimdex, Amnio Technology LLC, TissueTech Inc. (BioTissue), Integra LifeSciences Corporation, Skye Biologics Inc., Amniox Medical Inc., Laboratoire CCD, Vivex Biologics Inc., Merakris Therapeutics, and Akorn Operating Company LLC.